Trials / Completed
CompletedNCT05794009
Virtual Reality Exercise Program for People with Type 2 Diabetes
An E-therapist: an Interactive Immersive Virtual Reality Exercise Program for People with Type 2 Diabetes
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 124 (actual)
- Sponsor
- The Hong Kong Polytechnic University · Academic / Other
- Sex
- All
- Age
- 55 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to examine the effectiveness of a virtual reality (VR) based rehabilitation protocol for improvement of blood glucose control and exercise compliance of patients. Subjects aged 55-85 diagnosed with Type 2 diabetes will be recruited. A written consent will be obtained from subjects. Subjects recruited will be randomly divided into one of the two groups. The VR group will receive an exercise program conducted in elderly centre or a control group will receive home exercise program. The 12-week exercise program will be conducted three times per week and each session will last for one hour. Assessment that takes about one hour to complete will be carried out at baseline, mid-way (6th week) and after the 12-week exercise training. Assessment items include physical, psychosocial and cognitive function. Also, blood test on HbA1c will be carried out at baseline and at the end of the 12-week training. During this course of research, subjects are strongly advised to stay with their present lifestyle and medication.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Immersive Virtual Reality Exercise (IVRE) | The IVRE program will include aerobic exercise, muscle strengthening exercise, balance and flexibility exercise. |
| OTHER | Home Exercise | Aerobic exercise, muscle strengthening exercise, balance and flexibility exercise at home. |
Timeline
- Start date
- 2022-06-01
- Primary completion
- 2024-12-25
- Completion
- 2024-12-25
- First posted
- 2023-03-31
- Last updated
- 2025-03-13
Locations
1 site across 1 country: Hong Kong
Source: ClinicalTrials.gov record NCT05794009. Inclusion in this directory is not an endorsement.